45 - Gene Editing/Gene Therapies: CLINICAL MANUFACTURE OF CRISPR/CAS9-BASED CYTOKINE-INDUCED SH2 PROTEIN (CISH) KNOCK-OUT (KO) TUMOR-INFILTRATING LYMPHOCYTES (TIL) FOR GASTROINTESTINAL (GI) CANCERS

Autor: Sumstad, D., Webber, B., Growe, M., Moriarity, B., Kadidlo, D., Starr, T., Johnson, M., Lou, E., Choudhry, M., McKenna, Jr., D.
Zdroj: In Cytotherapy May 2022 24(5) Supplement:S41-S41
Databáze: ScienceDirect